OverviewSuggest Edit

Premier Biomedical, Inc. is a research-based firm that develops cures for Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis, and Cancer. 

TypePublic
Founded2010
HQJackson Center, US
Websitepremierbiomedical.com

Latest Updates

Employees (est.) (Dec 2018)2
Revenue (FY, 2019)$14.3 K(-64%)
Share Price (May 2020)$0 (-5%)

Key People/Management at Premier Biomedical

William A. Hartman

William A. Hartman

President and Chief Executive Officer and Board Member
Mitchell S. Felder

Mitchell S. Felder

Chairman of the Board of Directors
Heidi H. Carl

Heidi H. Carl

Chief Financial Officer and Board Member
Patricio F. Reyes

Patricio F. Reyes

Chief Technical Officer, Board Member
Show more

Premier Biomedical Office Locations

Premier Biomedical has an office in Jackson Center
Jackson Center, US (HQ)
Jackson Center, PA 16133, USA
Show all (1)

Premier Biomedical Financials and Metrics

Premier Biomedical Revenue

Premier Biomedical's revenue was reported to be $14.28 k in FY, 2019
USD

Revenue (FY, 2019)

14.3k

Gross profit (FY, 2019)

1.4k

Gross profit margin (FY, 2019), %

10%

Net income (FY, 2019)

(374.5k)

EBIT (FY, 2019)

(326.7k)

Market capitalization (21-May-2020)

1.7m

Closing stock price (21-May-2020)

0.0

Cash (31-Dec-2019)

71.2k

EV

1.7m
Premier Biomedical's current market capitalization is $1.7 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

39.8k39.8k14.3k

Cost of goods sold

25.4k113.7k12.9k

Gross profit

14.3k(73.9k)1.4k

Gross profit Margin, %

36%(186%)10%
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

24.3k10.4k12.1k8.2k5.7k3.8k3.5k

Cost of goods sold

11.1k6.1k10.1k4.4k2.1k1.8k1.7k

Gross profit

13.2k4.3k1.9k3.9k3.7k2.0k1.8k

Gross profit Margin, %

54%42%16%47%64%54%52%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

40.3k15.8k102.6k35.4k22.4k83.7k86.8k71.2k

Accounts Receivable

171.5m312.03.1k2.3k

Prepaid Expenses

69.06.0k9.5k9.2k34.8k43.9k

Inventories

84.8k26.0k13.1k
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.5k52.3k73.4k173.4k45.3k73.7k113.6k199.4k46.7k95.9k26.5k73.4k38.7k38.6k27.8k209.9k125.3k102.5k79.2k10.3k63.2k81.2k87.0k117.2k

Accounts Receivable

834.02.0k2.4k2.0k3.4k

Prepaid Expenses

563.0375.0187.0563.0375.0187.05.5k32.2k14.6k4.5k8.3k8.9k15.8k11.5k13.0k9.5k17.7k7.4k33.3k35.8k38.1k40.0k35.4k36.5k

Inventories

108.0k79.4k123.4k119.2k23.9k22.2k20.5k
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(1.7m)(4.9m)(1.4m)(2.6m)(1.8m)(3.8m)(398.9k)(374.5k)

Depreciation and Amortization

201.0767.0954.01.5k2.1k2.3k2.3k2.8k

Inventories

84.8k28.9k(13.1k)

Accounts Payable

86.3k33.7k25.2k40.8k32.5k126.1k(82.4k)(76.4k)
USDY, 2019

EV/EBIT

-5.2 x

EV/CFO

-4.9 x

Financial Leverage

-0.1 x
Show all financial metrics

Premier Biomedical Online and Social Media Presence

Embed Graph

Premier Biomedical News and Updates

Uptick Newswire Hosts the CEO of Premier Biomedical, Inc. to Talk About Exciting Deals on the Horizon with Distributors and the Launch of New Products in 2019

PHOENIX, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast features Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases, which has expanded into topical h…

Premier Biomedical, Inc.’s CEO Discusses a Bright Future for His Company and All-Natural Solutions with Uptick Newswire’s Stock Day Podcast

PHOENIX, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases. and provide all-natural, 50-state-legal topical pain relief products. CEO …

Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast

PHOENIX, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB:BIEI) (“Premier Biomedical, Inc.” or the “company”) is looking for new strategies and joint ventures to sell CBD. CEO and President of Premier Biomedical, Inc., William A. Hartman, talked with Stock Day’s Everett Jolly abou…

Premier Biomedical Frequently Asked Questions

  • When was Premier Biomedical founded?

    Premier Biomedical was founded in 2010.

  • Who are Premier Biomedical key executives?

    Premier Biomedical's key executives are William A. Hartman, Mitchell S. Felder and Heidi H. Carl.

  • How many employees does Premier Biomedical have?

    Premier Biomedical has 2 employees.

  • What is Premier Biomedical revenue?

    Latest Premier Biomedical annual revenue is $14.3 k.

  • What is Premier Biomedical revenue per employee?

    Latest Premier Biomedical revenue per employee is $7.1 k.

  • Who are Premier Biomedical competitors?

    Competitors of Premier Biomedical include AbbVie, Athersys and Otonomy.

  • Where is Premier Biomedical headquarters?

    Premier Biomedical headquarters is located at Jackson Center, PA 16133, USA, Jackson Center.

  • Where are Premier Biomedical offices?

    Premier Biomedical has an office in Jackson Center.

  • How many offices does Premier Biomedical have?

    Premier Biomedical has 1 office.